Movement Alert｜GE HEALTHCARE TECHNOLOGIES INC Rises 7.46% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Reaffirmed

Market Focus

07/29

On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.

The rally was driven by the company's Q2 earnings release, which showed adjusted EPS of $1.13, significantly exceeding the consensus estimate of $1.04, with net income reaching $561 million. Simultaneously, the company reaffirmed its full-year adjusted EPS guidance range of $4.80 to $5.00, aligning with the FactSet consensus estimate of $4.88.

This reaffirmation carries particular significance as the company had previously lowered its full-year EPS guidance from $4.95-$5.15 during Q1 due to surging memory chip, oil, and freight costs. The maintained outlook signals that cost pressures have been effectively managed. Additionally, management indicated that Patient Care Solutions segment supply conditions are expected to improve in the second half, which should benefit both sales and margins. The company also highlighted its strategic focus on artificial intelligence to enhance productivity and strengthen supply chain resilience.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1177411618"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177411618\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177411618?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-29 21:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177411618","market":"us","top_or_hot":-1,"title":"Movement Alert｜GE HEALTHCARE TECHNOLOGIES INC Rises 7.46% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Reaffirmed","media":"Market Focus","content":"<p><p>On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.</p><p>The rally was driven by the company's Q2 earnings release, which showed adjusted EPS of $1.13, significantly exceeding the consensus estimate of $1.04, with net income reaching $561 million. Simultaneously, the company reaffirmed its full-year adjusted EPS guidance range of $4.80 to $5.00, aligning with the FactSet consensus estimate of $4.88.</p><p>This reaffirmation carries particular significance as the company had previously lowered its full-year EPS guidance from $4.95-$5.15 during Q1 due to surging memory chip, oil, and freight costs. The maintained outlook signals that cost pressures have been effectively managed. Additionally, management indicated that Patient Care Solutions segment supply conditions are expected to improve in the second half, which should benefit both sales and margins. The company also highlighted its strategic focus on artificial intelligence to enhance productivity and strengthen supply chain resilience.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜GE HEALTHCARE TECHNOLOGIES INC Rises 7.46% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Reaffirmed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜GE HEALTHCARE TECHNOLOGIES INC Rises 7.46% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Reaffirmed\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time smaller\">2026-07-29 21:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><p>On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.</p><p>The rally was driven by the company's Q2 earnings release, which showed adjusted EPS of $1.13, significantly exceeding the consensus estimate of $1.04, with net income reaching $561 million. Simultaneously, the company reaffirmed its full-year adjusted EPS guidance range of $4.80 to $5.00, aligning with the FactSet consensus estimate of $4.88.</p><p>This reaffirmation carries particular significance as the company had previously lowered its full-year EPS guidance from $4.95-$5.15 during Q1 due to surging memory chip, oil, and freight costs. The maintained outlook signals that cost pressures have been effectively managed. Additionally, management indicated that Patient Care Solutions segment supply conditions are expected to improve in the second half, which should benefit both sales and margins. The company also highlighted its strategic focus on artificial intelligence to enhance productivity and strengthen supply chain resilience.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GEHC","symbol_name":"GE HEALTHCARE TECHNOLOGIES INC","start_time":0,"source_url":"","article_id":"1177411618","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177411618","pubTimestamp":1785331937,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.The rally was driven by the company's Q2 earnings release, which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GEHC":"GE HEALTHCARE TECHNOLOGIES INC"},"translate_title":"走势警报|GE HEALTHCARE TECHNOLOGIES INC 常规交易中上涨 7.46%，第二季度盈利超出预期，全年指引重申","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GEHC":1},"content_text":"On July 29, GE HEALTHCARE TECHNOLOGIES INC rose 7.46% in regular trading, trading at $68.9/share, with turnover of $66.528 million.The rally was driven by the company's Q2 earnings release, which showed adjusted EPS of $1.13, significantly exceeding the consensus estimate of $1.04, with net income reaching $561 million. Simultaneously, the company reaffirmed its full-year adjusted EPS guidance range of $4.80 to $5.00, aligning with the FactSet consensus estimate of $4.88.This reaffirmation carries particular significance as the company had previously lowered its full-year EPS guidance from $4.95-$5.15 during Q1 due to surging memory chip, oil, and freight costs. The maintained outlook signals that cost pressures have been effectively managed. Additionally, management indicated that Patient Care Solutions segment supply conditions are expected to improve in the second half, which should benefit both sales and margins. The company also highlighted its strategic focus on artificial intelligence to enhance productivity and strengthen supply chain resilience.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}